Repligen Corp
RGEN· Nasdaq
RGENRepligen Corp
Filed Mar 14, 2014 · 10-K · 73 days after period end · 0001193125-14-099241
| Metric | Q4 2013 | Q4 2012 | Q4 2011 |
|---|---|---|---|
| Revenue | $15.38M | $18.81M | $7.17M |
| Net Income | $3.33M | $9.55M | -$2.16M |
| EPS Diluted | $0.10 | $0.30 | -$0.07 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Repligen Corp · CIK 730272 · Engraved from SEC EDGAR
ended Dec 31, 2013 · filed Mar 14, 2014 · 73 d after period end
